1. Home
  2. VVV vs CYTK Comparison

VVV vs CYTK Comparison

Compare VVV & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVV
  • CYTK
  • Stock Information
  • Founded
  • VVV 1866
  • CYTK 1997
  • Country
  • VVV United States
  • CYTK United States
  • Employees
  • VVV N/A
  • CYTK N/A
  • Industry
  • VVV Major Chemicals
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVV Industrials
  • CYTK Health Care
  • Exchange
  • VVV Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • VVV 4.0B
  • CYTK 4.6B
  • IPO Year
  • VVV 2016
  • CYTK 2004
  • Fundamental
  • Price
  • VVV $31.46
  • CYTK $66.27
  • Analyst Decision
  • VVV Buy
  • CYTK Strong Buy
  • Analyst Count
  • VVV 12
  • CYTK 15
  • Target Price
  • VVV $42.83
  • CYTK $77.87
  • AVG Volume (30 Days)
  • VVV 1.7M
  • CYTK 1.9M
  • Earning Date
  • VVV 11-19-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • VVV N/A
  • CYTK N/A
  • EPS Growth
  • VVV 68.45
  • CYTK N/A
  • EPS
  • VVV 2.14
  • CYTK N/A
  • Revenue
  • VVV $1,692,000,000.00
  • CYTK $87,211,000.00
  • Revenue This Year
  • VVV $6.79
  • CYTK $363.61
  • Revenue Next Year
  • VVV $13.19
  • CYTK $64.33
  • P/E Ratio
  • VVV $14.67
  • CYTK N/A
  • Revenue Growth
  • VVV 7.53
  • CYTK 2609.26
  • 52 Week Low
  • VVV $30.77
  • CYTK $29.31
  • 52 Week High
  • VVV $43.20
  • CYTK $67.07
  • Technical
  • Relative Strength Index (RSI)
  • VVV 33.55
  • CYTK 66.82
  • Support Level
  • VVV $30.77
  • CYTK $58.05
  • Resistance Level
  • VVV $32.47
  • CYTK $66.98
  • Average True Range (ATR)
  • VVV 0.82
  • CYTK 2.66
  • MACD
  • VVV 0.04
  • CYTK 0.32
  • Stochastic Oscillator
  • VVV 20.60
  • CYTK 94.06

About VVV Valvoline Inc.

Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: